Smeland EB - Search Results

1

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma.

Josefsson SE, Beiske K, Blaker YN, Førsund MS, Holte H, Østenstad B, Kimby E, Köksal H, Wälchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH. Josefsson SE, et al. Among authors: smeland eb. Cancer Immunol Res. 2019 Mar;7(3):355-362. doi: 10.1158/2326-6066.CIR-18-0351. Epub 2019 Jan 18. Cancer Immunol Res. 2019. PMID: 30659053 Free PMC article.

2

[Immunophenotyping of leukemias].

Smeland EB, Beiske K. Smeland EB, et al. Tidsskr Nor Laegeforen. 1992 Aug 10;112(18):2373-4. Tidsskr Nor Laegeforen. 1992. PMID: 1412241 Norwegian. No abstract available.

3

Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells.

Stokke T, Holte H, Smeland EB, Lie SO, Steen HB. Stokke T, et al. Among authors: smeland eb. Cancer Res. 1992 Sep 15;52(18):5007-12. Cancer Res. 1992. PMID: 1516056

4

Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes.

Erikstein BK, Funderud S, Beiske K, Aas-Eng A, De Lange Davies C, Blomhoff HK, Smeland EB. Erikstein BK, et al. Among authors: smeland eb. Eur J Immunol. 1992 May;22(5):1149-55. doi: 10.1002/eji.1830220507. Eur J Immunol. 1992. PMID: 1577059

5

Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation.

Funderud S, Erikstein B, Asheim HC, Nustad K, Stokke T, Blomhoff HK, Holte H, Smeland EB. Funderud S, et al. Among authors: smeland eb. Eur J Immunol. 1990 Jan;20(1):201-6. doi: 10.1002/eji.1830200129. Eur J Immunol. 1990. PMID: 1689662

6

Inhibition of polyphosphoinositide breakdown and c-myc induction accompanying inhibition of human B-cell activation by two monoclonal antibodies against the leucocyte common antigen (CD45).

Smeland EB, Holte H, Kiil Blomhoff H, Asheim HC, Stokke T, Torjesen P, Funderud S. Smeland EB, et al. Scand J Immunol. 1990 May;31(5):583-91. doi: 10.1111/j.1365-3083.1990.tb02809.x. Scand J Immunol. 1990. PMID: 1693226

7

Differential effects of interferon-gamma and low molecular weight BCGF on growth of human B lymphocytes; interferon-gamma prolongs the increased c-MYC mRNA levels after activation.

Lømo J, Smeland EB, Stokke T, Holte H, Funderud S, Blomhoff HK. Lømo J, et al. Among authors: smeland eb. Scand J Immunol. 1991 Apr;33(4):365-73. doi: 10.1111/j.1365-3083.1991.tb01783.x. Scand J Immunol. 1991. PMID: 1902001

8

Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias.

Skjønsberg C, Erikstein BK, Smeland EB, Lie SO, Funderud S, Beiske K, Blomhoff HK. Skjønsberg C, et al. Among authors: smeland eb. Blood. 1991 Jun 1;77(11):2445-50. Blood. 1991. PMID: 2039826 Free article.

9

Immunological typing of acute leukaemias by rosetting with immunomagnetic beads: comparison with immunofluorescence staining.

Skjønsberg C, Kiil Blomhoff H, Gaudernack G, Funderud S, Beiske K, Smeland EB. Skjønsberg C, et al. Among authors: smeland eb. Scand J Immunol. 1990 May;31(5):567-73. doi: 10.1111/j.1365-3083.1990.tb02807.x. Scand J Immunol. 1990. PMID: 2189214

10

Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.

Smeland EB, Blomhoff HK, Holte H, Ruud E, Beiske K, Funderud S, Godal T, Ohlsson R. Smeland EB, et al. Exp Cell Res. 1987 Jul;171(1):213-22. doi: 10.1016/0014-4827(87)90264-3. Exp Cell Res. 1987. PMID: 2442015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters